Highly bioavailable anticancer herbal-loaded nanocarriers for use against breast and colon cancer in vitro and in vivo systems
Polymer Chemistry, ISSN: 1759-9962, Vol: 4, Issue: 6, Page: 2040-2052
2013
- 11Citations
- 14Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
This study focused on designing a large-scale producible vehicle for the pharmaceutically important compound berberine, to simultaneously improve its bioavailability against cancer cells and reduce cytotoxicity toward normal cells. This vehicle is composed of chitosan and tripolyphosphate, and was prepared with a simple ionic cross-linking method. The properties of the berberine-loaded chitosan-tripolyphosphate nanoparticles (BB-LCTNP) were dependent on berberine, chitosan, and tripolyphosphate concentrations. The bioavailability improvement and anticancer efficiency of the BB-LCTNPs were analyzed using MDA-MB-435 and Colo-205 cells. The results revealed that the particle size, loading efficiency, and IC of the BB-LCTNPs can be controlled easily. The pharmacodynamic availability of berberine increased up to 3 times when loaded into the nanoparticles because they directly targeted cancer cell nuclei. Moreover, the BB-LCTNPs were non-toxic toward normal cells. In vivo studies revealed that BB-LCTNPs can reduce drug dosages up to 3 times and suppress tumor growth. The surfaces of the prepared BB-LCTNPs were modified using mPEG acid, but the in vitro and in vivo studies of these particles are currently ongoing. © The Royal Society of Chemistry 2013.
Bibliographic Details
Royal Society of Chemistry (RSC)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know